Adipokines: Therapeutic targets for metabolic syndrome

Kunihisa Kobayashi, Toyoshi Inoguchi

    Research output: Contribution to journalReview articlepeer-review

    20 Citations (Scopus)


    For a long time it has been known that obesity (adiposity) is linked to insulin resistance. Recently, many investigators have reported that adipocytes secrete a variety of bioactive molecules, termed adipokines (adipocytokines), including TNFα, IL-6, leptin, adiponectin, resistin and so on. These adipokines play pivotal roles in energy homeostasis by affecting insulin sensitivity, glucose and lipid metabolisms, food intake, the coagulation system and inflammation. This review provides a summary of these adipose tissue-secreting biomolecules and discusses their feasibilities as drug targets for the treatment of metabolic syndrome.

    Original languageEnglish
    Pages (from-to)525-529
    Number of pages5
    JournalCurrent Drug Targets
    Issue number4
    Publication statusPublished - Jun 2005

    All Science Journal Classification (ASJC) codes

    • Molecular Medicine
    • Pharmacology
    • Drug Discovery
    • Clinical Biochemistry


    Dive into the research topics of 'Adipokines: Therapeutic targets for metabolic syndrome'. Together they form a unique fingerprint.

    Cite this